{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:34:27Z","timestamp":1788240867523,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08229-2","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:29:59Z","timestamp":1751434199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Appropriate target range of INR and predictive factors of recurrent thrombosis and bleeding in patients with venous thromboembolism on warfarin"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8247-8255","authenticated-orcid":false,"given":"Peerasit","family":"Sae-Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3900-460X","authenticated-orcid":false,"given":"Pirun","family":"Saelue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"8229_CR1","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1160\/TH17-02-0134","volume":"117","author":"LH Lee","year":"2017","unstructured":"Lee, L. H., Gallus, A., Jindal, R., Wang, C. & Wu, C. C. Incidence of venous thromboembolism in Asian populations: A systematic review. Thromb. Haemost. 117, 2243\u20132260 (2017).","journal-title":"Thromb. Haemost"},{"key":"8229_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.114.009107","volume":"130","author":"KK S\u00f8gaard","year":"2014","unstructured":"S\u00f8gaard, K. K., Schmidt, M., Pedersen, L., Horv\u00e1th-Puh\u00f3, E. & S\u00f8rensen, H. T. 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation 130, 829\u2013836 (2014).","journal-title":"Circulation"},{"key":"8229_CR3","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel, T. L. et al. American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 4, 4693\u20134738 (2020).","journal-title":"Blood Adv."},{"key":"8229_CR4","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.3390\/ijerph20043176","volume":"20","author":"S Niyomsri","year":"2023","unstructured":"Niyomsri, S., Nimworapan, M., Wongcharoen, W. & Dilokthornsakul, P. Economic evaluation of direct oral anticoagulants compared to warfarin for venous thromboembolism in thailand: A cost-utility analysis. Int. J. Environ. Res. Public. Health. 20, 3176 (2023).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"8229_CR5","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.jacc.2020.07.070","volume":"76","author":"E Renner","year":"2020","unstructured":"Renner, E. & Barnes, G. D. Antithrombotic management of venous thromboembolism: JACC focus seminar. J. Am. Coll. Cardiol. 76, 2142\u20132154 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"8229_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11239-015-1319-y","volume":"41","author":"DM Witt","year":"2016","unstructured":"Witt, D. M., Clark, N. P., Kaatz, S., Schnurr, T. & Ansell, J. E. Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. J. Thromb. Thrombolysis. 41, 187\u2013205 (2016).","journal-title":"J. Thromb. Thrombolysis"},{"key":"8229_CR7","doi-asserted-by":"crossref","unstructured":"Ageno, W. et al. Oral anticoagulant therapy: Antithrombotic therapy and prevention of thrombosis. Chest  9th ed. 141 (2) Suppl, e44S\u2013e88S (American College of Chest Physicians evidence-based clinical practice guidelines, 2012).","DOI":"10.1378\/chest.11-2292"},{"key":"8229_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2141.2011.08753.x","volume":"154","author":"D Keeling","year":"2011","unstructured":"Keeling, D. et al. Guidelines on oral anticoagulation with warfarin \u2013 fourth edition. Br. J. Haematol. 154, 311\u2013324 (2011). 4th ed.","journal-title":"Br. J. Haematol."},{"key":"8229_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/01.STR.31.4.817","volume":"31","author":"T Yamaguchi","year":"2000","unstructured":"Yamaguchi, T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial. Japanese nonvalvular atrial Fibrillation-Embolism secondary prevention cooperative study group. Stroke 31, 817\u2013821 (2000).","journal-title":"Stroke"},{"key":"8229_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-2125.2005.02361.x","volume":"59","author":"JHS You","year":"2005","unstructured":"You, J. H. S., Chan, F. W. H., Wong, R. S. M. & Cheng, G. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? Br. J. Clin. Pharmacol. 59, 582\u2013587 (2005).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"8229_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1056\/NEJMoa035241","volume":"349","author":"MA Crowther","year":"2003","unstructured":"Crowther, M. A. et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl. J. Med. 349, 1133\u20131138 (2003).","journal-title":"N Engl. J. Med."},{"key":"8229_CR12","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1538-7836.2005.01340.x","volume":"3","author":"G Finazzi","year":"2005","unstructured":"Finazzi, G. et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J. Thromb. Haemost. 3, 848\u2013853 (2005).","journal-title":"J. Thromb. Haemost"},{"key":"8229_CR13","doi-asserted-by":"publisher","first-page":"d813","DOI":"10.1136\/bmj.d813","volume":"342","author":"J Douketis","year":"2011","unstructured":"Douketis, J. et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 342, d813 (2011).","journal-title":"BMJ"},{"key":"8229_CR14","doi-asserted-by":"publisher","first-page":"E121","DOI":"10.1503\/cmaj.121218","volume":"185","author":"T Gomes","year":"2013","unstructured":"Gomes, T. et al. Rates of hemorrhage during warfarin therapy for atrial fibrillation. CMAJ 185, E121\u2013E127 (2013).","journal-title":"CMAJ"},{"key":"8229_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","volume":"1","author":"Y Wan","year":"2008","unstructured":"Wan, Y. et al. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ. Cardiovasc. Qual. Outcomes. 1, 84\u201391 (2008).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"8229_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.thromres.2008.09.016","volume":"124","author":"CL Morgan","year":"2009","unstructured":"Morgan, C. L. et al. Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. Thromb. Res. 124, 37\u201341 (2009).","journal-title":"Thromb. Res."},{"key":"8229_CR17","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani, S. S. et al. Heart disease and stroke Statistics-2020 update: A report from the American heart association. Circulation 141, e139\u2013e596 (2020).","journal-title":"Circulation"},{"key":"8229_CR18","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","volume":"10","author":"A Tosetto","year":"2012","unstructured":"Tosetto, A. et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J. Thromb. Haemost. 10, 1019\u20131025 (2012).","journal-title":"J. Thromb. Haemost"},{"key":"8229_CR19","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","volume":"121","author":"S Eichinger","year":"2010","unstructured":"Eichinger, S., Heinze, G., Jandeck, L. M. & Kyrle, P. A. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation 121, 1630\u20131636 (2010).","journal-title":"Circulation"},{"key":"8229_CR20","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1182\/blood-2015-04-641225","volume":"126","author":"T Tritschler","year":"2015","unstructured":"Tritschler, T., M\u00e9an, M., Limacher, A., Rodondi, N. & Aujesky, D. Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna prediction model. Blood 126, 1949\u20131951 (2015).","journal-title":"Blood"},{"key":"8229_CR21","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1111\/jth.13154","volume":"13","author":"K Sundquist","year":"2015","unstructured":"Sundquist, K., Sundquist, J., Svensson, P. J., Z\u00f6ller, B. & Memon, A. A. Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study. J. Thromb. Haemost. 13, 2180\u20132186 (2015).","journal-title":"J. Thromb. Haemost"},{"key":"8229_CR22","doi-asserted-by":"crossref","unstructured":"MC, G. L. G., Ps, W. & Ma, R. Systematic review: Case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann. Intern. Med., 152.  https:\/\/pubmed.ncbi.nlm.nih.gov\/20439576\/ (2010).","DOI":"10.7326\/0003-4819-152-9-201005040-00008"},{"key":"8229_CR23","unstructured":"Zhang, G., Xu, X., Su, W. & Xu, Q. P. Smoking and risk of venous thromboembolism: a systematic review. Southeast Asian J. Trop. Med. Public Health https:\/\/www.semanticscholar.org\/paper\/Smoking-and-risk-of-venous-thromboembolism%3A-a-Zhang-Xu\/ead12db79c04146bd3eb857ff8098b48ac88c1ad  (2014)."},{"key":"8229_CR24","doi-asserted-by":"publisher","first-page":"e1001515","DOI":"10.1371\/journal.pmed.1001515","volume":"10","author":"YJ Cheng","year":"2013","unstructured":"Cheng, Y. J. et al. Current and former smoking and risk for venous thromboembolism: A systematic review and meta-analysis. PLOS Med. 10, e1001515 (2013).","journal-title":"PLOS Med."},{"key":"8229_CR25","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1111\/j.1538-7836.2012.04880.x","volume":"10","author":"KF Enga","year":"2012","unstructured":"Enga, K. F. et al. Cigarette smoking and the risk of venous thromboembolism: the Troms\u00f8 study. J. Thromb. Haemost. 10, 2068\u20132074 (2012).","journal-title":"J. Thromb. Haemost"},{"key":"8229_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5152\/TJAR.2019.08683","volume":"48","author":"B Al-Nasser","year":"2020","unstructured":"Al-Nasser, B. Influence of tobacco smoking on perioperative risk of venous thromboembolism. Turk. J. Anaesthesiol. Reanim. 48, 11\u201316 (2020).","journal-title":"Turk. J. Anaesthesiol. Reanim"},{"key":"8229_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.21037\/apm.2017.11.01","volume":"7","author":"C Johnstone","year":"2018","unstructured":"Johnstone, C. & Rich, S. E. Bleeding in cancer patients and its treatment: a review. Ann. Palliat. Med. 7, 265\u2013273 (2018).","journal-title":"Ann. Palliat. Med."},{"key":"8229_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1055\/a-2347-6507","volume":"45","author":"C Englisch","year":"2025","unstructured":"Englisch, C., Vladic, N. & Ay, C. Bleeding risk in patients with cancer. H\u00e4mostaseologie 45, 188\u2013203 (2025).","journal-title":"H\u00e4mostaseologie"},{"key":"8229_CR29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1055\/s-0040-1708481","volume":"120","author":"A Abdulla","year":"2020","unstructured":"Abdulla, A. et al. A meta-analysis of case fatality rates of recurrent venous thromboembolism and major bleeding in patients with cancer. Thromb. Haemost. 120, 702\u2013713 (2020).","journal-title":"Thromb. Haemost"},{"key":"8229_CR30","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1345\/aph.19289","volume":"34","author":"RY Chenhsu","year":"2000","unstructured":"Chenhsu, R. Y., Chiang, S. C., Chou, M. H. & Lin, M. F. Long-term treatment with warfarin in Chinese population. Ann. Pharmacother. 34, 1395\u20131401 (2000).","journal-title":"Ann. Pharmacother"},{"key":"8229_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa035422","volume":"349","author":"C Kearon","year":"2003","unstructured":"Kearon, C. et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl. J. Med. 349, 631\u2013639 (2003).","journal-title":"N Engl. J. Med."},{"key":"8229_CR32","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1111\/crj.12795","volume":"12","author":"R Jiang","year":"2018","unstructured":"Jiang, R. et al. Comparative efficacy and safety of low-intensity warfarin therapy in preventing unprovoked recurrent venous thromboembolism: A systematic review and meta-analysis. Clin. Respir J. 12, 2170\u20132177 (2018).","journal-title":"Clin. Respir J."},{"key":"8229_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","volume":"69","author":"FR Rosendaal","year":"1993","unstructured":"Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. & Bri\u00ebt, E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb. Haemost. 69, 236\u2013239 (1993).","journal-title":"Thromb. Haemost"},{"key":"8229_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2147\/VHRM.S264814","volume":"16","author":"FA Aleidan","year":"2020","unstructured":"Aleidan, F. A. The cumulative incidence and risk factors of recurrent venous thromboembolism in the elderly. Vasc Health Risk Manag. 16, 437\u2013443 (2020).","journal-title":"Vasc Health Risk Manag"},{"key":"8229_CR35","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1001\/archinte.164.20.2260","volume":"164","author":"PD Stein","year":"2004","unstructured":"Stein, P. D. et al. Venous thromboembolism according to age: the impact of an aging population. Arch. Intern. Med. 164, 2260\u20132265 (2004).","journal-title":"Arch. Intern. Med."},{"key":"8229_CR36","doi-asserted-by":"publisher","first-page":"102194","DOI":"10.1016\/j.eclinm.2023.102194","volume":"64","author":"MAM van Hylckama Vlieg","year":"2023","unstructured":"van Hylckama Vlieg, M. A. M. et al. The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis. EClinicalmedicine 64, 102194 (2023).","journal-title":"EClinicalmedicine"},{"key":"8229_CR37","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1182\/blood-2014-01-549733","volume":"123","author":"CE Chee","year":"2014","unstructured":"Chee, C. E. et al. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood 123, 3972\u20133978 (2014).","journal-title":"Blood"},{"key":"8229_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejim.2023.02.003","volume":"112","author":"MC Vedovati","year":"2023","unstructured":"Vedovati, M. C. et al. Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism. Eur. J. Intern. Med. 112, 29\u201336 (2023).","journal-title":"Eur. J. Intern. Med."},{"key":"8229_CR39","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1182\/bloodadvances.2019000369","volume":"3","author":"H Al-Samkari","year":"2019","unstructured":"Al-Samkari, H. & Connors, J. M. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy. Blood Adv. 3, 3770\u20133779 (2019).","journal-title":"Blood Adv."},{"key":"8229_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/ejh.13177","volume":"102","author":"JJ Shatzel","year":"2019","unstructured":"Shatzel, J. J. et al. Venous thrombosis in unusual sites: A practical review for the hematologist. Eur. J. Haematol. 102, 53\u201362 (2019).","journal-title":"Eur. J. Haematol."},{"key":"8229_CR41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/rth2.12482","volume":"5","author":"W Ageno","year":"2021","unstructured":"Ageno, W. et al. Provoked versus unprovoked venous thromboembolism: findings from Garfield-VTE. Res. Pract. Thromb. Haemost. 5, 326\u2013341 (2021).","journal-title":"Res. Pract. Thromb. Haemost"},{"key":"8229_CR42","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/jth.13336","volume":"14","author":"C Kearon","year":"2016","unstructured":"Kearon, C. et al. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J. Thromb. Haemost. 14, 1480\u20131483 (2016).","journal-title":"J. Thromb. Haemost"},{"key":"8229_CR43","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","volume":"13","author":"S Kaatz","year":"2015","unstructured":"Kaatz, S., Ahmad, D., Spyropoulos, A. C., Schulman, S. & Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J. Thromb. Haemost. 13, 2119\u20132126 (2015).","journal-title":"J. Thromb. Haemost"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08229-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08229-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08229-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:30:04Z","timestamp":1751434204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08229-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8229"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08229-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23463"}}